Table 1.
Characteristics of patients tested and positive for SARS-CoV-2 and hospitalized for COVID-19
| Tested patients No. (%) | Positive patients No. (%) | Hospitalized patients No. (%) | |
|---|---|---|---|
| Socio-demographics | |||
| Total no. of patients | 629,953 | 54,645 | 8,536 |
| Age (years) | 51.5 ± 19.4 | 47.8 ± 19.2 | 64.7 ± 17.6 |
| Sex | |||
| Female | 359,246 (57.0%) | 28,765 (52.6%) | 3,885 (45.5%) |
| Male | 270,707 (43.0%) | 25,880 (47.4%) | 4,651 (54.5%) |
| Known race/ethnicity | 570,298 (90.5%) | 49,081 (89.8%) | 8,210 (96.2%) |
| Hispanic | 76,300 (13.4%) | 16,836 (34.3%) | 2,898 (35.3%) |
| Black | 21,709 (3.8%) | 2,066 (4.2%) | 368 (4.5%) |
| Asian | 30,736 (5.4%) | 2,456 (5.0%) | 533 (6.5%) |
| NH/PI | 3,460 (0.6%) | 468 (1.0%) | 98 (1.2%) |
| AI/AN | 5,201 (0.9%) | 434 (0.9%) | 77 (0.9%) |
| White | 411,852 (72.2%) | 24,468 (49.9%) | 3,751 (45.7%) |
| Other | 21,040 (3.7%) | 2,353 (4.8%) | 485 (5.9%) |
| Unknown race/ethnicity | 59,655 (9.5%) | 5,564 (10.2%) | 326 (3.8%) |
| Insurance | |||
| Commercial | 280,300/616,048 (45.5%) | 23,617/52,764 (44.8%) | 1,494/8,432 (17.7%) |
| Medicaid | 184,547/616,048 (30.0%) | 20,937/52,764 (39.7%) | 4,327/8,432 (51.3%) |
| Medicare | 146,041/616,048 (23.7%) | 6,989/52,764 (13.2%) | 2,495/8,432 (29.6%) |
| Uninsured/Self-pay | 5,001/616,048 (0.8%) | 1,211/52,764 (2.3%) | 113/8,432 (1.3%) |
| Other insurance | 159/616,048 (0.0%) | 10/52,764 (0.0%) | 3/8,432 (0.0%) |
| Neighborhood-level | |||
| Median income | 74,604 ± 25,144 | 68,522 ± 21,589 | 68,843 ± 22,432 |
| % Crowded housing | 4.4 ± 4.6 | 6.4 ± 6.4 | 7.8 ± 7.1 |
| % Minority | 34.3 ± 21.4 | 42.4 ± 26.3 | 49.4 ± 27.0 |
| % Limited English | 9.3 ± 8.6 | 12.8 ± 10.5 | 15.9 ± 11.3 |
| Comorbidities | |||
| Hypertension | 146,957 (23.3%) | 10,847 (19.8%) | 3,433 (40.2%) |
| Diabetes | 59,452 (9.4%) | 5,946 (10.9%) | 2,419 (28.3%) |
| Weight | |||
| Underweight | 11,719/548,795 (2.1%) | 781/47,184 (1.7%) | 262/8,503 (3.1%) |
| Normal | 159,034/548,795 (29.0%) | 11,277/47,184 (23.9%) | 2,070/8,503 (24.3%) |
| Overweight | 174,105/548,795 (31.7%) | 15,363/47,184 (32.6%) | 2,573/8,503 (30.3%) |
| Class 1 Obesity | 108,833/548,795 (19.8%) | 10,499/47,184 (22.3%) | 1,801/8,503 (21.2%) |
| Class 2 Obesity | 52,914/548,795 (9.6%) | 5,214/47,184 (11.1%) | 924/8,503 (10.9%) |
| Class 3 Obesity | 42,190/548,795 (7.7%) | 4,050/47,184 (8.6%) | 873/8,503 (10.3%) |
| Chronic respiratory disease | |||
| Asthma | 40,808 (6.5%) | 2,894 (5.3%) | 574 (6.7%) |
| COPD | 25,313 (4.0%) | 1,424 (2.6%) | 712 (8.3%) |
| Cardiovascular disease | |||
| Coronary artery disease | 34,549 (5.5%) | 1,976 (3.6%) | 829 (9.7%) |
| Myocardial Infarction | 13,979 (2.2%) | 872 (1.6%) | 473 (5.5%) |
| Congestive heart failure | 33,675 (5.3%) | 2,128 (3.9%) | 1,129 (13.2%) |
| Kidney disease | 35,154 (5.6%) | 2,897 (5.3%) | 1,469 (17.2%) |
| Liver disease | 19,772 (3.1%) | 1,353 (2.5%) | 345 (4.0%) |
| Cancer | 38,453 (6.1%) | 1,663 (3.0%) | 539 (6.3%) |
| Charlson Comorbidity Index | 1.0 (0.0 – 3.0) | 0.0 (0.0 – 2.0) | 3.0 (2.0 – 6.0) |
| Geographic distribution | |||
| California | 157,407 (25.0%) | 18,701 (34.2%) | 4,237 (49.6%) |
| Oregon | 167,874 (26.6%) | 13,486 (24.7%) | 1,047 (12.3%) |
| Washington | 304,672 (48.4%) | 22,458 (41.1%) | 3,252 (38.1%) |